ARCHIVES

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

Monica Bertagnolli Elected Chair Of The Alliance For Clinical Trials In Oncology

July 15, 2011

ASBMT Installs New Officers

March 14, 2003

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010